| 1. |
Jones P. T., Dear P. H., Foote J., Neuberger M. S., and Winter G. (1986). Replacing the complementarity determining regions
in a human antibody with those from a mouse. Nature
321, 522–525.
|
| |
| 2. |
Reichmann L., Clark M., Waldmann H., Winter G. (1988). Reshaping human antibodies for therapy. Nature
332, 323–327.
|
| |
| 3. |
Kozak M. (1987). At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol.
196, 947–950.
<Occurrence Type="DOI"><Handle>10.1016/0022-2836(87)90418-9</Handle></Occurrence>
|
| |
| 4. |
Kettleborough C. A., Saldanha J., Heath V. J., Morrison C. J., and Bendig M. M. (1991). Humanization of a mouse monoclonal
antibody by CDR-grafting: the importance of framework residues on loop conformation. Protein Eng.
4, 773–783.
|
| |
| 5. |
Maeda H., Matsushita S., Eda Y., Kimachi K., Tokiyoshi S., and Bendig M. M. (1991). Humanization of a mouse monoclonal antibody
by CDR-grafting: the importance of framework residues on loop conformation. Hum. Antibod Hybridomas
2, 124–134.
|
| |
| 6. |
Chothia C. and Lesk A. M. (1987). Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol.
196, 901–917.
<Occurrence Type="DOI"><Handle>10.1016/0022-2836(87)90412-8</Handle></Occurrence>
|
| |
| 7. |
Chothia C., Lesk A. M., Gherardi E., Tomlinson I. M., Walter G., Marks J. D., et al. (1992). Structural repertoire of the
human VH segments. J. Mol. Biol.
227, 799–817.
<Occurrence Type="DOI"><Handle>10.1016/0022-2836(92)90224-8</Handle></Occurrence>
|
| |
| 8. |
Chothia C., Lesk A. M., Tramontano A., Levitt M., Smith-Gill S. J., Air G., et al. (1989). Conformations of immunoglobulin
hypervariable regions. Nature
34, 877–883.
|
| |
| 9. |
Tramontano A., Chothia C., and Lesk A. M. (1990). Framework residue 71 is a major determinant of the position and conformation
of the second hypervariable region in the VH domains of immunoglobulins. J. Mol. Biol.
215, 175–181.
<Occurrence Type="DOI"><Handle>10.1016/S0022-2836(05)80102-0</Handle></Occurrence>
|
| |
| 10. |
Sato K., Tsuchiya M., Saldanha J., Koishihara Y., Ohsugi Y., Kishimoto T. and Bendig M. M. (1993). Reshaping a human antibody
to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res.
53, 851–856.
|
| |
| 11. |
Stemmer W. P. C. (1995). Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.
Gene
146, 49–53.
<Occurrence Type="DOI"><Handle>10.1016/0378-1119(95)00511-4</Handle></Occurrence>
|
| |
| 12. |
Chomczynski P. and Sacchi N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal. Biochem.
162, 156–159.
<Occurrence Type="DOI"><Handle>10.1016/0003-2697(87)90021-2</Handle></Occurrence>
|
| |
| 13. |
Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., and Foeller C. (1991) Sequences of Proteins of Immunological Interest,
5th ed. U.S. Department of Health and Human Services, U.S. Government Printing Office Washington, DC.
|
| |
| 14. |
Foote J. and Winter G. (1992). Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol.
224, 487–499.
<Occurrence Type="DOI"><Handle>10.1016/0022-2836(92)91010-M</Handle></Occurrence>
|
| |
| 15. |
Mountain A. and Adair J. R. (1992). Engineering antibodies for therapy. Biotechnol. Genet. Eng. Rev.
10, 1–142.
|
| |
| 16. |
Pisano A., Redmond J. W., Williams K. L., and Gooley A. A. (1993). Glycosylatioin sited identified by solid-phase Edman degradation:
O-linked glycosylation motifs on human glycophorin A. Glycobiology
3, 429–435.
|
| |